Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (901-910 of 1,467) with videos related to

Pageof 147
Sort By:
Rheumatology (Oxford, England)|August 21, 2001
Serum interleukin-15 is elevated in systemic lupus erythematosusM Aringer, G H Stummvoll, G Steiner, et al.
The Journal of Rheumatology. Supplement|June 2, 2004
Leflunomide: a manageable safety profilePeit L C M van Riel, Josef S Smolen, Paul Emery, et al.
Annals of the Rheumatic Diseases|February 13, 2007
Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapyJohannes Grisar, Daniel Aletaha, Carl W Steiner, et al.
Rheumatology (Oxford, England)|December 18, 2015
Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritisMichael Bonelli, Lisa Göschl, Stephan Blüml, et al.
Acta Biomaterialia|October 27, 2015
Controlled release of fibrin matrix-conjugated platelet derived growth factor improves ischemic tissue regeneration by functional angiogenesisRainer Mittermayr, Paul Slezak, Nicolas Haffner, et al.
Arthritis Care & Research|January 10, 2018
Benefits and Sustainability of a Learning Collaborative for Implementation of Treat-to-Target in Rheumatoid Arthritis: Results of a Cluster-Randomized Controlled Phase II Clinical TrialDaniel H Solomon, Bing Lu, Zhi Yu, et al.
Annals of the Rheumatic Diseases|July 2, 2024
Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatmentEugen Feist, Roy M Fleischmann, Saeed Fatenejad, et al.
Annals of the Rheumatic Diseases|November 3, 2023
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving storyMichael Bonelli, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 19, 2020
Research productivity during orthopedic surgery residency correlates with pre-planned and protected research time: a survey of German-speaking countriesAndreas Voss, Björn Andreß, Leo Pauzenberger, et al.
The American Journal of Pathology|January 27, 2004
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritisKurt Redlich, Birgit Görtz, Silvia Hayer, et al.
Pageof 147

Showing results (901-910 of 1,467) with videos related to

Sort By:
Pageof 147
Rheumatology (Oxford, England)|August 21, 2001
Serum interleukin-15 is elevated in systemic lupus erythematosusM Aringer, G H Stummvoll, G Steiner, et al.
The Journal of Rheumatology. Supplement|June 2, 2004
Leflunomide: a manageable safety profilePeit L C M van Riel, Josef S Smolen, Paul Emery, et al.
Annals of the Rheumatic Diseases|February 13, 2007
Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapyJohannes Grisar, Daniel Aletaha, Carl W Steiner, et al.
Rheumatology (Oxford, England)|December 18, 2015
Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritisMichael Bonelli, Lisa Göschl, Stephan Blüml, et al.
Acta Biomaterialia|October 27, 2015
Controlled release of fibrin matrix-conjugated platelet derived growth factor improves ischemic tissue regeneration by functional angiogenesisRainer Mittermayr, Paul Slezak, Nicolas Haffner, et al.
Arthritis Care & Research|January 10, 2018
Benefits and Sustainability of a Learning Collaborative for Implementation of Treat-to-Target in Rheumatoid Arthritis: Results of a Cluster-Randomized Controlled Phase II Clinical TrialDaniel H Solomon, Bing Lu, Zhi Yu, et al.
Annals of the Rheumatic Diseases|July 2, 2024
Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatmentEugen Feist, Roy M Fleischmann, Saeed Fatenejad, et al.
Annals of the Rheumatic Diseases|November 3, 2023
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving storyMichael Bonelli, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 19, 2020
Research productivity during orthopedic surgery residency correlates with pre-planned and protected research time: a survey of German-speaking countriesAndreas Voss, Björn Andreß, Leo Pauzenberger, et al.
The American Journal of Pathology|January 27, 2004
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritisKurt Redlich, Birgit Görtz, Silvia Hayer, et al.
Pageof 147